Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

Sex-differential effects of adjuvanted and non-adjuvanted rabies vaccines on all-cause mortality in a novel animal model: understanding non-specific effects of vaccines in high-mortality populations

Award Number: R21AI151356
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 03/16/2020
PERIOD OF PERFORMANCE END DATE: 02/29/2024

Group Awards By:

View Award Description

Sex-differential effects of adjuvanted and non-adjuvanted rabies vaccines on all-cause mortality in a novel animal model: understanding non-specific effects of vaccines in high-mortality populations - The theory of non-specific effects (NSEs) of vaccines proposes that vaccines in high-mortality populations have substantial impacts on mortality rates that are not explained by the prevention of targeted diseases, nor conversely by typical expected adverse reactions to the vaccines, and that these NSEs are generally more pronounced in females. The existence of these effects, and any implications for the development of vaccines and the design of vaccination programs to enhance safety, remain controversial. The long-term goal of the proposed research is to contribute to the overall understanding of vaccine safety in high-mortality populations, through the study of NSEs in a novel animal model system, free-roaming domestic dogs. The overall objectives in this application are (i) to confirm preliminary data that adjuvanted, non-live animal rabies vaccine (ARV) substantially increases all-cause mortality rates in female but not male animals in this system, (ii) to determine if non-adjuvanted, non-live human rabies vaccine (HRV) also has an effect on all-cause mortality in dogs that is modified by sex, and (iii) to quantify the extent to which the sex-differential effect of vaccine type on mortality is mediated by the nature of the immune response elicited. The central hypothesis is that adjuvanted ARV in dogs has a detrimental effect on female survival by modulating the immune response to infectious and/or parasitic diseases to which females are normally less susceptible than males, and that non-adjuvanted HRV will not have this same detrimental effect. The rationale for this project is that controlled studies of NSEs at low risk of bias are needed to achieve scientific consensus on the topic, and that while such studies may be challenging to conduct in children in high-mortality settings, they are ethically and logistically feasible in the proposed animal model system. The central hypothesis will be tested by pursuing two specific aims: 1) Determine if ARV and HRV have an effect on survival in dogs that is modified by sex, and 2) Determine to what extent the effect of vaccine type on survival is mediated by a shift towards a Th2-type cytokine response shortly after vaccination. These aims will be achieved in a randomized, three-arm, owner-blind, sham- controlled animal trial. Dogs will be randomly allocated to one of 3 treatment groups (ARV, HRV or sham- injection). The primary outcome will be death due to any cause. For the second aim, statistical mediation analysis will be used to quantify what proportion of the effect of vaccine type on survival is mediated through a shift towards a Th2-type cytokine response following vaccination. The research proposed in this application is innovative because it focuses on establishment of an animal model for randomized controlled trials at low risk of bias in high-mortality populations, which will allow for integration of studies of mechanistic links between vaccine exposures, immunological changes and non-specific survival outcomes. The research is significant because it is expected to provide evidence of sex-differential non-specific effects of non-live vaccines in a high- mortality population. Ultimately, such knowledge may offer new opportunities to enhance vaccine safety.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2024 ( Subtotal = $0 )
2024	2021	ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE	WEST FARM	BASSETERRE				KNA	Allergy and Infectious Diseases Research	000	2	9/19/2024	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2023 ( Subtotal = $0 )
2023	2021	ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE	WEST FARM	BASSETERRE				KNA	Allergy and Infectious Diseases Research	000	2	2/8/2023	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2022 ( Subtotal = $0 )
2022	2021	ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE	WEST FARM	BASSETERRE	NULL			KNA	Allergy and Infectious Diseases Research	000	2	3/8/2022	NON-COMPETING CONTINUATION	$0
2022	2021	ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE	WEST FARM	BASSETERRE	NULL			KNA	Allergy and Infectious Diseases Research	001	2	3/15/2022	NON-COMPETING CONTINUATION	$0
														Subtotal = $0

Issue Date FY: 2021 ( Subtotal = $123,224 )
2021	2021	ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE	WEST FARM	BASSETERRE				KNA	Allergy and Infectious Diseases Research	000	2	2/18/2021	NON-COMPETING CONTINUATION	$123,224
														Subtotal = $123,224

Issue Date FY: 2020 ( Subtotal = $165,835 )
2020	2020	ROSS UNIVERSITY SCHOOL OF VETERINARY MEDICINE	WEST FARM	BASSETERRE				KNA	Allergy and Infectious Diseases Research	000	1	3/16/2020	NEW	$165,835
														Subtotal = $165,835

Grand Total All Awards = $289,059

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Sex-differential effects of adjuvanted and non-adjuvanted rabies vaccines on all-cause mortality in a novel animal model: understanding non-specific effects of vaccines in high-mortality populations

Award Number: R21AI151356

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 03/16/2020

PERIOD OF PERFORMANCE END DATE: 02/29/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer